Home › Companies › Viridian Therapeutics, Inc.
How asset managers voted at Viridian Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Viridian Therapeutics, Inc. | 5 | 236 |
| 2024-2025 | Viridian Therapeutics, Inc. | 7 | 197 |
| 2023-2024 | VIRIDIAN THERAPEUTICS INC. | 5 | 162 |
Earlier seasons list this company under the name VIRIDIAN THERAPEUTICS INC., as its holders filed it.
Explore Viridian Therapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 13, 2026.